Zobrazeno 1 - 10
of 19
pro vyhledávání: '"E. V. Kokhan"'
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 17, Iss 3, Pp 429-437 (2021)
Aim. To study the impact of heart rate (HR) reduction with beta-blockers (BB) on left atrial (LA) function in hypertensive patients with paroxysmal or persistent mild symptomatic atrial fibrillation.Material and methods. In this open prospective tria
Externí odkaz:
https://doaj.org/article/685ac7ed335945e98076c0762d460dba
Autor:
Z. D. Kobalava, E. V. Kokhan
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 16, Iss 5, Pp 842-851 (2020)
Despite the widespread awareness that hypertension and dyslipidemia are risk factors of prime importance for cardiovascular disease, the prevalence of these risk factors is still high, and the success of their control can hardly be considered satisfa
Externí odkaz:
https://doaj.org/article/19e60fc4f04b4dc082ef7b7171286e02
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 15, Iss 5, Pp 622-633 (2019)
Aim. To evaluate gender-related differences of left atrial (LA) phasic function and structural remodeling in conjunction with the parameters of left ventricular (LV) diastolic dysfunction and central aortic pressure in patients with hypertension and
Externí odkaz:
https://doaj.org/article/53a88056e0e0466bb78fd77cf48ec6bf
Publikováno v:
Российский кардиологический журнал, Vol 25, Iss 1 (2020)
The review discusses the prognostic value and contribution to therapy optimization of lung ultrasound for heart failure patients.
Externí odkaz:
https://doaj.org/article/a694a1a101d143eba68cf2bb430e12d6
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 13, Iss 4, Pp 541-549 (2017)
Today there is enough data on gender differences in regard to epidemiology, pathogenesis and prognostic value of atrial fibrillation (AF). Left atrial structural and functional changes associated with development and persistence of AF can be more sig
Externí odkaz:
https://doaj.org/article/e7a503fc77e44000984b3c59782369a8
Publikováno v:
Racionalʹnaâ Farmakoterapiâ v Kardiologii, Vol 17, Iss 3, Pp 429-437 (2021)
Aim. To study the impact of heart rate (HR) reduction with beta-blockers (BB) on left atrial (LA) function in hypertensive patients with paroxysmal or persistent mild symptomatic atrial fibrillation.Material and methods. In this open prospective tria
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0d18deb1b24c5937347253c6cbbf4fe5
https://doi.org/10.20996/1819-6446-2021-06-08
https://doi.org/10.20996/1819-6446-2021-06-08
Autor:
E. V. Kokhan, Zh. D. Kobalava
Publikováno v:
Racionalʹnaâ Farmakoterapiâ v Kardiologii, Vol 16, Iss 5, Pp 842-851 (2020)
Despite the widespread awareness that hypertension and dyslipidemia are risk factors of prime importance for cardiovascular disease, the prevalence of these risk factors is still high, and the success of their control can hardly be considered satisfa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6553e2248413ad4e42d828760c64dfdd
https://www.rpcardio.com/jour/article/view/2315
https://www.rpcardio.com/jour/article/view/2315
Autor:
E. V. Kokhan, Zh. D. Kobalava
Publikováno v:
Kardiologiia. 60:122-133
Cardiovascular diseases remain a leading cause for unfavorable outcomes, including death, in patients with type 2 diabetes mellitus (DM2). In the recent decade, novel drugs, including glucagon-like peptide-1 receptor agonists (GPP-1-RA) and sodium-gl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7f41a0698f4937abed189152593ae853
https://doi.org/10.18087/cardio.2020.9.n1274
https://doi.org/10.18087/cardio.2020.9.n1274
Frequency of use and Indications for Beta-Blockers in Heart Failure with Preserved Ejection Fraction
Publikováno v:
Kardiologiia. 60:30-40
Aim To evaluate trends in beta-blocker prescribing and incidence of possible reasons for beta-blocker administration, including arterial hypertension (AH), atrial fibrillation (AF), ischemic heart disease (IHD), and myocardial infarction, in particip
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e7896932b64c0f478f21dfa2f6bd6dc7
https://doi.org/10.18087/cardio.2020.6.n1062
https://doi.org/10.18087/cardio.2020.6.n1062
Publikováno v:
"Arterial’naya Gipertenziya" ("Arterial Hypertension"). 25:376-388
Several recent large studies, most of which were performed in Denmark, have revealed a link between hydrochlorothiazide use and the risk of non-melanoma skin cancer. Photosensitizing properties of hydrochlorothiazide, inherent in many antihypertensiv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1eb342fdbf69eaff2455789735dffbb6
https://doi.org/10.18705/1607-419x-2019-25-4-376-388
https://doi.org/10.18705/1607-419x-2019-25-4-376-388